Events > Breaking Barriers: Targeted Protein Degradation in Oncology and Beyond
  August 8, 2024 Aug 2024

Breaking Barriers: Targeted Protein Degradation in Oncology and Beyond

Despite significant advancements in drug development, classical drug discovery is still unable to target more than 75% of proteins. Target protein degraders (TPDs) can target intracellular proteins through modified cellular protein degradation mechanisms, and will transform treatments in oncology and other indications in the coming decades.

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.

Terms of Use
Privacy Policy
Cookie Policy
  • © 2021 Cheers Interactive (India) Private Limited. All rights reserved. FutureBridge ® is a registered trademark of Cheers Interactive (India) Private Limited. Crafted by pixelmattic